Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial

Peer Review reports

Original Submission
15 Jun 2016	Submitted	Original manuscript
28 Dec 2016	Reviewed	Reviewer Report - Bernardino Alcazar
12 May 2017	Author responded	Author comments - Peter Saunders
Resubmission - Version 2
12 May 2017	Submitted	Manuscript version 2
24 May 2017	Reviewed	Reviewer Report - Ravana Sfalcin
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
25 May 2017	Editorially accepted
15 Jun 2017	Article published	10.1186/s13063-017-2016-2

Back to article page